NHSGGC Bio-repository and Pathology Tissue Resource II

• Research type

  Research Tissue Bank

• IRAS ID

  199711

• Research summary

  NHSGGC Bio-repository. The main aim in establishing a Biorepository is to provide the infrastructure to underpin the process of access to well annotated samples for medical research purposes

• REC name

  West of Scotland REC 4

• REC reference

  16/WS/0207

• Date of REC Opinion

  14 Mar 2017

• REC opinion

  Further Information Favourable Opinion

• Data collection arrangements

  The NHSGGC Biorepository main tissue acquisition activity is based within the Laboratory Medicine Building on the Queen Elizabeth University Hospital (QEUH) campus.
  The tissue storage facilities are based on the QEUH campus as well as a new facility on the WGAC Campus in Yorkhill.
  All samples stored in these research tissue banks have the patient’s permission for their tissue to be used in research

  The NHSGGC Pathology Department provides a centralised operational diagnostic service based in a new purpose built facility in the Laboratory Medicine Building on the QEUH campus. The Pathology department diagnostic tissue archives, associated with the service, are also held on this site as well as at other acute hospitals across NHSGGC. The Pathology diagnostic archive is considered to be part of the patient’s medical record (and for medical legal purposes) and the length of time this is stored for is in accordance with the Royal College of Pathologists retention guidelines. The Formalin Paraffin Blocks (FFPB’s) for example must be retained for a minimum of thirty years.

  The diagnostic tissue resource also includes surplus tissue available from the other Diagnostics Laboratory Medicine Laboratories, including, Haematology, Biochemistry, Microbiology, Immunology, Virology and Medical Genetics.

• Research programme

  The main aim in establishing a Biorepository is to provide the infrastructure to underpin and streamline the process of research tissue acquisition and disbursement, according to local and national strategic priorities. Core funding of this facility is through the Scottish Government Chief Scientist Office (CSO) under the auspices of the NHS National Research Scotland (NRS) with monies administered by the NHS R&D offices. The purpose of the NRS is developing the national research infrastructure to facilitate medical research and innovation and increase our competitiveness within the UK and globally. A key resource in translational and clinical research including delivery of Precision or Stratified Medicine is a Biorepository network, which facilitates the discovery of disease mechanisms and treatments. The NRS Bio-repository network will be a key component of the “Precision Medicine Ecosystem for Scotland “. A key priority of the Biorepository is therefore to ensure its activity is closely aligned to the research strategies set out by the CSO as well as those of the local and UK research community.

• RTBTitle

  NHSGGC Bio-repository. The main aim in establishing a Biorepository is to provide the infrastructure to underpin the process of access to well annotated samples for medical research purposes

• Establishment organisation

  NHSGGC Bio-repository

• Establishment organisation address

  Level 3, Laboratory Medicine Building

  Queen Elizabeth University Hospital, 1345 Govan Road

  Glasgow

  G51 4TY